152 related articles for article (PubMed ID: 28975625)
1. Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.
Dalasanur Nagaprashantha L; Adhikari R; Singhal J; Chikara S; Awasthi S; Horne D; Singhal SS
Int J Cancer; 2018 Feb; 142(4):658-670. PubMed ID: 28975625
[TBL] [Abstract][Full Text] [Related]
2. Are plant-based functional foods better choice against cancer than single phytochemicals? A critical review of current breast cancer research.
Kapinova A; Stefanicka P; Kubatka P; Zubor P; Uramova S; Kello M; Mojzis J; Blahutova D; Qaradakhi T; Zulli A; Caprnda M; Danko J; Lasabova Z; Busselberg D; Kruzliak P
Biomed Pharmacother; 2017 Dec; 96():1465-1477. PubMed ID: 29198744
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Breast Cancer by Natural Phytochemicals: Focusing on Molecular Targets and Combinational Strategy.
Chiou YS; Li S; Ho CT; Pan MH
Mol Nutr Food Res; 2018 Dec; 62(23):e1800392. PubMed ID: 30168668
[TBL] [Abstract][Full Text] [Related]
4. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention.
Kapinova A; Kubatka P; Golubnitschaja O; Kello M; Zubor P; Solar P; Pec M
Environ Health Prev Med; 2018 Aug; 23(1):36. PubMed ID: 30092754
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.
Dago DN; Scafoglio C; Rinaldi A; Memoli D; Giurato G; Nassa G; Ravo M; Rizzo F; Tarallo R; Weisz A
BMC Genomics; 2015 May; 16(1):367. PubMed ID: 25956916
[TBL] [Abstract][Full Text] [Related]
6. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of dual targeting in HER2-positive breast cancer.
Kümler I; Tuxen MK; Nielsen DL
Cancer Treat Rev; 2014 Mar; 40(2):259-70. PubMed ID: 24080156
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer.
Lv Q; Meng Z; Yu Y; Jiang F; Guan D; Liang C; Zhou J; Lu A; Zhang G
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983617
[TBL] [Abstract][Full Text] [Related]
9. Tea phytochemicals for breast cancer prevention and intervention: From bench to bedside and beyond.
Sinha D; Biswas J; Nabavi SM; Bishayee A
Semin Cancer Biol; 2017 Oct; 46():33-54. PubMed ID: 28396252
[TBL] [Abstract][Full Text] [Related]
10. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
Paris O; Ferraro L; Grober OM; Ravo M; De Filippo MR; Giurato G; Nassa G; Tarallo R; Cantarella C; Rizzo F; Di Benedetto A; Mottolese M; Benes V; Ambrosino C; Nola E; Weisz A
Oncogene; 2012 Sep; 31(38):4196-206. PubMed ID: 22231442
[TBL] [Abstract][Full Text] [Related]
11. Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.
Sohel M; Aktar S; Biswas P; Amin MA; Hossain MA; Ahmed N; Mim MIH; Islam F; Mamun AA
Cancer Med; 2023 Jul; 12(13):14556-14583. PubMed ID: 37132286
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
Dandawate PR; Subramaniam D; Jensen RA; Anant S
Semin Cancer Biol; 2016 Oct; 40-41():192-208. PubMed ID: 27609747
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapeutics and Molecular Mechanism of Phytochemicals in Alleviating Hormone-Responsive Breast Cancer.
Rampogu S; Park C; Ravinder D; Son M; Baek A; Zeb A; Bavi R; Kumar R; Lee G; Parate S; Pawar SC; Park Y; Park SJ; Lee KW
Oxid Med Cell Longev; 2019; 2019():5189490. PubMed ID: 31089409
[TBL] [Abstract][Full Text] [Related]
15. Potential phytocompounds for developing breast cancer therapeutics: Nature's healing touch.
Iqbal J; Abbasi BA; Batool R; Mahmood T; Ali B; Khalil AT; Kanwal S; Shah SA; Ahmad R
Eur J Pharmacol; 2018 May; 827():125-148. PubMed ID: 29535002
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor signaling as a target for novel breast cancer therapeutics.
Renoir JM; Marsaud V; Lazennec G
Biochem Pharmacol; 2013 Feb; 85(4):449-65. PubMed ID: 23103568
[TBL] [Abstract][Full Text] [Related]
17. Co-targeting estrogen receptor and HER2 pathways in breast cancer.
Mehta A; Tripathy D
Breast; 2014 Feb; 23(1):2-9. PubMed ID: 24176518
[TBL] [Abstract][Full Text] [Related]
18. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of breast cancer by dietary compounds.
Vadodkar AS; Suman S; Lakshmanaswamy R; Damodaran C
Anticancer Agents Med Chem; 2012 Dec; 12(10):1185-202. PubMed ID: 22583403
[TBL] [Abstract][Full Text] [Related]
20. Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention.
Babashah S; Bakhshinejad B; Birgani MT; Pakravan K; Cho WC
Curr Cancer Drug Targets; 2018; 18(7):640-651. PubMed ID: 28669335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
